Straumann latest to wield axe with 150 job cuts, as Q3 sales "slightly weak"
This article was originally published in Clinica
The global dental implant market leader Straumann has become the latest medtech firm to turn to restructuring to combat tough market conditions – the company has revealed plans to cut around 150 staff, or 6% of its workforce by early 2013.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.